ZA200109073B - Compositions for treatment of disorders of the oesophagus. - Google Patents

Compositions for treatment of disorders of the oesophagus.

Info

Publication number
ZA200109073B
ZA200109073B ZA200109073A ZA200109073A ZA200109073B ZA 200109073 B ZA200109073 B ZA 200109073B ZA 200109073 A ZA200109073 A ZA 200109073A ZA 200109073 A ZA200109073 A ZA 200109073A ZA 200109073 B ZA200109073 B ZA 200109073B
Authority
ZA
South Africa
Prior art keywords
oesophagus
disorders
compositions
treatment
Prior art date
Application number
ZA200109073A
Other languages
English (en)
Inventor
Dettmar Peter William
Dickson Paul Andrew
Frank Hampson
Chadwick Jolliffe Ian Gardon
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of ZA200109073B publication Critical patent/ZA200109073B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200109073A 1999-05-05 2001-11-01 Compositions for treatment of disorders of the oesophagus. ZA200109073B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9910212.1A GB9910212D0 (en) 1999-05-05 1999-05-05 Improvements in or relating to organic compositions

Publications (1)

Publication Number Publication Date
ZA200109073B true ZA200109073B (en) 2003-01-29

Family

ID=10852720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109073A ZA200109073B (en) 1999-05-05 2001-11-01 Compositions for treatment of disorders of the oesophagus.

Country Status (15)

Country Link
US (1) US6610667B1 (https=)
EP (2) EP1614431B1 (https=)
JP (1) JP2002544176A (https=)
CN (1) CN1173743C (https=)
AR (1) AR023876A1 (https=)
AT (2) ATE417602T1 (https=)
AU (1) AU774966B2 (https=)
BR (1) BR0010209A (https=)
CA (1) CA2371031C (https=)
DE (2) DE60023873T2 (https=)
ES (1) ES2251997T3 (https=)
GB (2) GB9910212D0 (https=)
PL (1) PL199445B1 (https=)
WO (1) WO2000067799A1 (https=)
ZA (1) ZA200109073B (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368013B (en) * 2001-02-19 2004-07-28 Richard Orlando Brown An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
ITRM20030154A1 (it) * 2003-04-03 2004-10-04 D M G Italia S R L Sciroppo antireflusso.
CN1780880B (zh) * 2003-04-25 2010-04-28 雷克特本克斯尔保健(英国)有限公司 可增稠的组合物
WO2006085987A2 (en) 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
US8597709B2 (en) 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
US8062686B2 (en) 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
EP1931222B1 (en) * 2005-10-05 2012-02-15 FMC Biopolymer AS Gelling compositions and methods
EP1859786A1 (en) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
BRPI0704542B8 (pt) * 2007-05-15 2021-05-25 Univ Estadual Campinas Unicamp composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
AU2014262248B2 (en) * 2007-07-30 2017-05-04 Inovobiologic, Inc. Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
EP2214679B1 (en) * 2007-11-13 2019-03-27 Meritage Pharma, Inc. Corticosteroid compositions
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
PL2240018T3 (pl) * 2008-01-04 2017-01-31 Schabar Res Ass Llc Kompozycja zawierająca środek przeciwbólowy i przeciwhistaminowy
AR070593A1 (es) * 2008-02-08 2010-04-21 Colgate Palmolive Co Composiciones efervescentes
PL2296670T3 (pl) 2008-05-13 2013-07-31 Apharm Srl Doustne zastosowanie glikozaminoglikanu i kompozycje
BRPI0912028A2 (pt) * 2008-05-15 2015-10-06 Firmenich & Cie sistema de liberação para um ingrediente ativo.
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
EP2435021B1 (en) 2009-05-25 2013-07-03 Pharcoterm S.R.L. Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US9636360B2 (en) * 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
IT201600088648A1 (it) * 2016-08-31 2018-03-03 Alpiflor S R L Composizione nutrizionale o farmaceutica ed integratore alimentare contenente detta compsizione nutrizionale o farmaceutica
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IT201600121617A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione per il trattamento del reflusso gastroesofageo
CN106420773A (zh) * 2016-12-21 2017-02-22 郑州莉迪亚医药科技有限公司 一种治疗放射性肠炎的中西药组合物及其制备方法和应用
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
IL312094A (en) * 2018-03-02 2024-06-01 Pharagen Llc Formulations treating acid reflux comprising sodium alginate
WO2019172261A1 (ja) * 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料
CN109432232B (zh) * 2018-12-07 2021-11-26 纽湃腾（北京）医药科技有限公司 一种改善调节胃食管反流的海藻酸盐组合物及应用
CN109432233A (zh) * 2018-12-07 2019-03-08 纽湃腾（北京）医药科技有限公司 一种含有猴头菇提取物的抑反流护胃组合物及应用
CN110840853A (zh) * 2019-10-26 2020-02-28 张强 胃镜检查用咀嚼或含化型口咽部局麻药及服用方法
US12514846B2 (en) 2020-07-15 2026-01-06 Schabar Research Associates Llc Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
CA3124579C (en) 2020-07-15 2026-03-31 Schabar Research Associates Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
EP4181912A1 (en) 2020-07-15 2023-05-24 Schabar Research Associates LLC Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
IT202000031421A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico
PL4262824T3 (pl) * 2020-12-18 2026-03-30 Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego
IT202000031433A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizioni comprendenti saccarosio octasolfato per il trattamento del reflusso gastrico
IT202000031409A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57133170A (en) * 1981-02-12 1982-08-17 Kikusui Kagaku Kogyo Kk Thermochromic coating compound with colorful pattern
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
PL170554B1 (pl) * 1991-12-17 1996-12-31 Fuisz Technologies Ltd Sposób wytwarzania kompozycji przeciwwrzodowej PL PL PL
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
GB9708773D0 (en) * 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same

Also Published As

Publication number Publication date
CA2371031A1 (en) 2000-11-16
DE60023873T2 (de) 2006-08-03
AU4590000A (en) 2000-11-21
EP1614431A2 (en) 2006-01-11
EP1173218B1 (en) 2005-11-09
US6610667B1 (en) 2003-08-26
WO2000067799A1 (en) 2000-11-16
ATE417602T1 (de) 2009-01-15
CN1173743C (zh) 2004-11-03
GB0010669D0 (en) 2000-06-28
AU774966B2 (en) 2004-07-15
PL199445B1 (pl) 2008-09-30
GB2349570B (en) 2002-05-22
ES2251997T3 (es) 2006-05-16
DE69940131D1 (de) 2009-01-29
CA2371031C (en) 2008-09-30
DE60023873D1 (de) 2005-12-15
BR0010209A (pt) 2002-02-19
CN1349418A (zh) 2002-05-15
EP1614431B1 (en) 2008-12-17
EP1173218A1 (en) 2002-01-23
GB9910212D0 (en) 1999-06-30
GB2349570A (en) 2000-11-08
ATE308997T1 (de) 2005-11-15
JP2002544176A (ja) 2002-12-24
EP1614431A3 (en) 2006-03-01
AR023876A1 (es) 2002-09-04
PL351134A1 (en) 2003-03-24

Similar Documents

Publication Publication Date Title
ZA200109073B (en) Compositions for treatment of disorders of the oesophagus.
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL145470A0 (en) Compositions for the treatment of immune diseases
MXPA03002814A (es) Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AP2004003002A0 (en) azabicyclic-substituted fused-heteroaryl compoundsfor the treatment of disease.
IL150742A0 (en) Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
ZA200108446B (en) Novel method of treatment.
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
ZA200108856B (en) Treatment of neurotic disorders.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
GB9925136D0 (en) Novel treatment
ZA200105690B (en) Novel treatment.
AU4498201A (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
IL133760A0 (en) Composition for the treatment of dandruff
ZA200109845B (en) Hair treatment compositions.
MXPA03004017A (es) Metodo para el tratamiento de inflamacion.
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
MXPA03001472A (es) Compuestos para el tratamiento de trastornos adictivos.
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
MXPA02003976A (es) Formulaciones de liberacion continua para el tratamiento de desordenes mediados por cns.
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AU2683500A (en) Compositions for the treatment of pain